[Revision of the national guideline 'Melanoma']

There is no fulltext present in this item.

Title:	[Revision of the national guideline 'Melanoma']
Author(s):	Veerbeek, L.; Kruit, W.H.; Wilt, J.H. de ; Mooi, W.J. ; Bergman, W.
Publication year:	2013
Source:	Nederlands Tijdschrift voor Geneeskunde, vol. 157, iss. 12, (2013), pp. A6136
ISSN:	0028-2162
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/117993
Display more details
Subject:	ONCOL 4: Quality of Care
Organization:	Surgery
Journal title:	Nederlands Tijdschrift voor Geneeskunde
Volume:	vol. 157
Issue:	iss. 12
Page start:	p. A6136
Abstract:	- Melanoma is in the top ten of the most common types of cancer in the Netherlands. Incidence is increasing steadily by about 4% every year.- The relative 5-year survival rate for patients with a melanoma with Breslow thickness < 1mm is about 98%.- The national guideline 'Melanoma version 2.0' is the result of an evidence based revision focussed on the most important bottlenecks encountered in clinical practice. The most important changes concern indications for sentinel node procedures (in patients with tumours stage 1b and higher) and multidisciplinary consultation (patients with stage 3 and 4 tumours).- The guideline is intended for all professionals involved in diagnosis, treatment and support of patients with melanoma of the skin.- Guideline summary cards and the 'Melanoma Pathway' ('Zorgpad Melanoom') are available at www.iknl.nl.- An English translation of the quideline will be available in April 2013 at www.oncoline.nl.